Markets:

Overview

News

Currencies

International

Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

17.29 -0.02 (-0.09%)

Streaming Delayed Price Updated: 3:43 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Bausch + Lomb Corporation Common Shares

< Previous 1 2 3 4 5 Next >

Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.

January 05, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Completes Refinancing of Outstanding Term B Loans

January 02, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference

December 23, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Two Board of Directors Appointments

December 17, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Refinancing of Outstanding Term B Loans

December 12, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Participate in Citi Global Healthcare Conference

November 18, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day

November 13, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program

November 10, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Hold Investor Day on Nov. 13

November 03, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Third-Quarter 2025 Results

October 29, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13

September 29, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial

September 11, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers

September 09, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States

September 08, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Board Changes

August 18, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Participate in Upcoming Investor Conferences

August 14, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Second-Quarter 2025 Results

July 30, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops

July 29, 2025

From Bausch + Lomb Corporation

Via Business Wire

Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity

July 22, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(NASDAQ:TEM) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye

July 01, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13

June 30, 2025

From Bausch + Lomb Corporation

Via Business Wire

BAUSCH & LOMB ALERT: Bragar Eagel & Squire, P.C. is Investigating Bausch + Lomb Corporation on Behalf of Bausch & Lomb Stockholders and Encourages Investors to Contact the Firm

June 26, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility

June 26, 2025

From Bausch + Lomb Corporation

Via Business Wire

Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

June 24, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

Bausch + Lomb Corporation (BLCO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

June 23, 2025

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

June 20, 2025

From Glancy Prongay & Murray LLP

Via Business Wire

Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering

June 18, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement

June 10, 2025

From Bausch + Lomb Corporation

Via Business Wire

BLCO Investors Have Opportunity to Join Bausch + Lomb Corporation Fraud Investigation with the Schall Law Firm

June 06, 2025

From The Schall Law Firm

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO

June 06, 2025

From Pomerantz LLP

Via GlobeNewswire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.